Table 3. Chlamydia infection in the PmpG vaccine cohort.
| PmpG Vaccine | ||||||
|---|---|---|---|---|---|---|
| Ocular Loads | UGT Loads | Chlamydiosis during the 6-month trial | Chlamydiosis post the 6-month trial | |||
| Months post-vaccine | Months post-vaccine | |||||
| 0 | 6 | 0 | 6 | |||
| P1 | BDL | BDL | BDL | BDL | N | N |
| P2 | BDL | BDL | BDL | BDL | N | N |
| P3 | BDL | BDL | BDL | BDL | N | N |
| P4 | BDL | BDL | BDL | BDL | N | Y |
| P5 | BDL | BDL | BDL | BDL | N | N |
| P6 | BDL | BDL | BDL | BDL | N | N |
| P7 | BDL | BDL | BDL | BDL | N | N |
| P8 | BDL | 1292 | BDL | 2290 | N | N |
| P9 | BDL | BDL | BDL | 230 | N | N |
| P10 | BDL | BDL | BDL | BDL | N | N |
| P11 | BDL | 167 | BDL | 346 | N | N |
| P12 | BDL | BDL | BDL | BDL | N | Y |
| P13 | BDL | BDL | BDL | BDL | N | N |
| P14 | BDL | BDL | BDL | BDL | N | N |
| P15 | BDL | BDL | BDL | BDL | N | N |
| P16 | BDL | BDL | BDL | BDL | N | N |
| P17 | BDL | BDL | BDL | BDL | N | N |
| P18 | BDL | BDL | BDL | BDL | N | N |
| P19 | BDL | BDL | BDL | BDL | N | N |
| P20 | BDL | BDL | BDL | BDL | N | N |
| P21 | BDL | BDL | BDL | BDL | N | N |
Infection with C. pecorum was assessed in the PmpG vaccine cohort using our C. pecorum 16S qPCR assay. Loads obtained are indicated for each koala in copies/μL of sample, pre and post-vaccination. BDL stands for Below Detection Level, and corresponds to <100 copies/μL. Clinical disease status were recorded for each koala whether it occurred during the trial or during the 3 months past the trial period.